NewsRx

Search our medical news database

Kendall Law Group

Kendall Law Group Investigates WuXi PharmaTech Cayman Inc. for Shareholders

Published in Healthcare Mergers, Acquisitions and Ventures Week, May 15th, 2010

Kendall Law Group, a national securities firm, is investigating WuXi PharmaTech (Cayman) Inc. (NYSE:WX) on behalf of shareholders after the announcement of a $1.6 billion merger agreement between WuXi and Charles River Laboratories, Inc. The firm's investigation is to determine if a fair process was used in shopping the company prior to entering into the agreement and whether the Board of Directors had breached their fiduciary duties by not seeking a deal that would provide better value of the company. WuXi shareholders, and anyone else with knowledge of the transaction, are encouraged to contact the Kendall Law Group by email at skendall@kendalllawgroup.com or 877-744-3728.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook